Current Neuropharmacology
Title:Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times
Volume: 19 Issue: 2
Author(s): Seyed Mohammad Nabavi*Eduardo Sobarzo-Sánchez*
Affiliation:
- Applied Biotechnology Research Center Baqiyatallah University of Medical Sciences Tehran, Sheikh Bahaei St., 19945-546,Iran
- Grupo de Investigación en Química Médica y Bio-inorgánica (QMEDBIN) Facultad de Ciencias de la Salud Universidad Central de Chile Lord Cochrane 417, Santiago,Spain
Export Options
About this article
Cite this article as:
Nabavi Mohammad Seyed *, Sobarzo-Sánchez Eduardo *, Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times, Current Neuropharmacology 2021; 19 (2) . https://dx.doi.org/10.2174/1570159X1902201231153120
DOI https://dx.doi.org/10.2174/1570159X1902201231153120 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Delirium in Older Patients – A Review
Current Psychiatry Reviews Incidence and Prevalence of Hypothyroidism in Patients Affected by Chronic Heart Failure: Role of Amiodarone
Endocrine, Metabolic & Immune Disorders - Drug Targets Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets Coffee: A Rich Source of Antimicrobial and Antiviral Compounds
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research The Pathology Induced by Highly Active Antiretroviral Therapy Against Human Immunodeficiency Virus: an Update
Current Medicinal Chemistry Redox Chemistry of Green Tea Polyphenols: Therapeutic Benefits in Neurodegenerative Diseases
Mini-Reviews in Medicinal Chemistry Viral Encephalitis: Current Treatments and Future Perspectives
Central Nervous System Agents in Medicinal Chemistry TAU Aggregation is a Therapeutic Target for Alzheimers Disease
Current Alzheimer Research Anandamide Dysfunction in Prodromal and Established Psychosis
Current Pharmaceutical Design Arundic Acid (ONO-2506) Ameliorates Delayed Ischemic Brain Damage by Preventing Astrocytic Overproduction of S100B
Current Drug Targets - CNS & Neurological Disorders A Series of Novel Neuroprotective Blood Brain Barrier Penetrating Flavonoid Drugs to Treat Acute Ischemic Stroke
Current Pharmaceutical Design Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases
Current Medicinal Chemistry Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease
Current Drug Targets Benefits of Resistance Training in Older Adults
Current Aging Science Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Vaccine Development for Alzheimers Disease
Current Pharmaceutical Design Metabolic and Cardiovascular Ageing Indices in Relation to Glycated Haemoglobin in Healthy and Diabetic Subjects
Current Aging Science Imaging of Glucose Uptake During Walking in Elderly Adults
Current Aging Science Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome
Current Alzheimer Research